[Evaluating efficiency of individual skin protective means in exposure to nickel compounds].
Evaluating efficiency of individual skin protective means, the author used complex of clinical and laboratory methods with consideration of etiopathogenetic mechanism underlying occupational allergic dermatosis.
Larkin
A A
AA
D000906:Antibodies / Q000276:immunology; D004277:DNA, Single-Stranded / Q000235:genetics; D009783:Dermatitis, Occupational / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D015227:Lipid Peroxidation; D009532:Nickel / Q000009:adverse effects*; D009707:Nucleosomes / Q000235:genetics / Q000276:immunology; D009824:Ointments / Q000627:therapeutic use*
D000906:Antibodies; D004277:DNA, Single-Stranded; D009707:Nucleosomes; D009824:Ointments; D009532:Nickel